An investigator sponsored, pilot clinical trial exploring the treatment of Non-Tuberculous Mycobacteria (NTM) with Thiolanox inhaled nitric oxide gas, using its unique computerized trace-gas delivery system

Trial Profile

An investigator sponsored, pilot clinical trial exploring the treatment of Non-Tuberculous Mycobacteria (NTM) with Thiolanox inhaled nitric oxide gas, using its unique computerized trace-gas delivery system

Planning
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Mycobacterial infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2017 New trial record
    • 31 Oct 2017 According to a Novoteris media release, the Therapeutic Products Directorate of Health Canada has cleared the clinical trial application for this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top